raloxifene has been researched along with Fibroid in 1 studies
raloxifene : A member of the class of 1-benzothiophenes that is 1-benzothiophene in which the hydrogens at positions 2, 3, and 6 have been replaced by p-hydroxyphenyl, p-[2-(piperidin-1-yl)ethoxy]benzoyl, and hydroxy groups, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hummel, CW | 1 |
| Geiser, AG | 1 |
| Bryant, HU | 1 |
| Cohen, IR | 1 |
| Dally, RD | 1 |
| Fong, KC | 1 |
| Frank, SA | 1 |
| Hinklin, R | 1 |
| Jones, SA | 1 |
| Lewis, G | 1 |
| McCann, DJ | 1 |
| Rudmann, DG | 1 |
| Shepherd, TA | 1 |
| Tian, H | 1 |
| Wallace, OB | 1 |
| Wang, M | 1 |
| Wang, Y | 1 |
| Dodge, JA | 1 |
1 other study available for raloxifene and Fibroid
| Article | Year |
|---|---|
A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats.
Topics: Animals; Binding Sites; Biological Availability; Cell Line; Cell Proliferation; Estradiol; Estrogen | 2005 |